HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $410,161 | +42.4% | 11,371 | +50.8% | 0.05% | +35.3% |
| Q1 2023 | $288,000 | -31.7% | 7,541 | +1.7% | 0.03% | -39.3% |
| Q4 2022 | $421,743 | +47.5% | 7,412 | +2.5% | 0.06% | +33.3% |
| Q3 2022 | $286,000 | -10.1% | 7,230 | 0.0% | 0.04% | -4.5% |
| Q2 2022 | $318,000 | +7.4% | 7,230 | -2.7% | 0.04% | +22.2% |
| Q1 2022 | $296,000 | +13.0% | 7,427 | +14.0% | 0.04% | +5.9% |
| Q4 2021 | $262,000 | -0.4% | 6,516 | +0.6% | 0.03% | -8.1% |
| Q3 2021 | $263,000 | -23.3% | 6,475 | -14.2% | 0.04% | -27.5% |
| Q2 2021 | $343,000 | +63.3% | 7,546 | +50.0% | 0.05% | -8.9% |
| Q1 2021 | $210,000 | +4.0% | 5,030 | +6.5% | 0.06% | +3.7% |
| Q4 2020 | $202,000 | – | 4,722 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |